XSHG600249
Market cap386mUSD
Dec 25, Last price
5.13CNY
1D
-2.29%
1Q
23.02%
Jan 2017
-43.93%
Name
Liuzhou Liangmianzhen Co Ltd
Chart & Performance
Profile
Liuzhou Liangmianzhen Co., Ltd. produces and sells oral care products in China, Hong Kong, Macau, North America, Western Europe, South Asia, and Africa. It offers toothpastes under the LMZ Herbal and Fangcao brand names; and toothbrushes and mouthwashes. The company also provides body care and facial care products; sanitary towels and papers; sucralose sweeteners; medical products comprising bulk drugs, tablets, capsules, and granules; and clothes cleaning, pesticide residue degrading, and dishwashing liquid products. In addition, it offers travel packages and kits; and develops real estate properties. The company was founded in 1941 and is headquartered in Liuzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 995,136 48.71% | 669,192 -6.74% | 717,526 4.68% | |||||||
Cost of revenue | 970,568 | 672,596 | 688,096 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 24,569 | (3,404) | 29,431 | |||||||
NOPBT Margin | 2.47% | 4.10% | ||||||||
Operating Taxes | 5,657 | |||||||||
Tax Rate | 23.02% | |||||||||
NOPAT | 18,912 | (3,404) | 29,431 | |||||||
Net income | 22,807 | 8,658 -85.08% | ||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 58,731 | 43,666 | 76,118 | |||||||
Long-term debt | 2,391 | 1,287 | 2,020 | |||||||
Deferred revenue | 8,150 | 8,708 | 8,811 | |||||||
Other long-term liabilities | 1,653 | 1,313 | 2,273 | |||||||
Net debt | (1,508,903) | (1,457,105) | (1,441,191) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 38,368 | 27,580 | ||||||||
CAPEX | (26,552) | |||||||||
Cash from investing activities | (5,089) | 667,967 | ||||||||
Cash from financing activities | 34,804 | |||||||||
FCF | 50,444 | 23,088 | 604,403 | |||||||
Balance | ||||||||||
Cash | 1,480,980 | 1,408,382 | 1,467,941 | |||||||
Long term investments | 89,044 | 93,677 | 51,388 | |||||||
Excess cash | 1,520,267 | 1,468,599 | 1,483,452 | |||||||
Stockholders' equity | 698,075 | 912,512 | 951,098 | |||||||
Invested Capital | 1,487,129 | 1,219,808 | 1,261,077 | |||||||
ROIC | 1.40% | 2.28% | ||||||||
ROCE | 1.10% | 1.30% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 549,558 | 550,000 | 550,000 | |||||||
Price | 5.84 11.24% | 5.25 -3.67% | 5.45 14.98% | |||||||
Market cap | 3,209,419 11.15% | 2,887,500 -3.67% | 2,997,500 14.98% | |||||||
EV | 1,700,517 | 1,430,395 | 1,556,309 | |||||||
EBITDA | 51,685 | 28,108 | 60,537 | |||||||
EV/EBITDA | 32.90 | 50.89 | 25.71 | |||||||
Interest | 1,741 | 1,410 | 1,316 | |||||||
Interest/NOPBT | 7.09% | 4.47% |